Drug Patent Expirations in February 2010
02. Feb, 2010 
0 Comments
Drug Patent Expirations in February 2010
*Drugs may be covered by multiple patents
| Tradename | Applicant | Generic Name | Patent Number | Patent Expiration |
|---|---|---|---|---|
| ZAGAM | Mylan | sparfloxacin | 4,795,751 | Feb 4, 2010 |
| TEVETEN | Abbott | eprosartan mesylate | 5,185,351 | Feb 9, 2010 |
| MYOVIEW | Ge Healthcare | technetium tc-99m tetrofosmin kit | 5,045,302 | Feb 9, 2010 |
| TEVETEN HCT | Abbott | eprosartan mesylate; hydrochlorothiazide | 5,185,351 | Feb 9, 2010 |
| HYZAAR | Merck | hydrochlorothiazide; losartan potassium | 5,138,069*PED | Feb 11, 2010 |
| COZAAR | Merck | losartan potassium | 5,138,069*PED | Feb 11, 2010 |
| EXUBERA | Pfizer | insulin recombinant human | RE37872 | Feb 12, 2010 |
| EXUBERA | Pfizer | insulin recombinant human | RE38385 | Feb 12, 2010 |
| MEPRON | Glaxosmithkline | atovaquone | 4,981,874*PED | Feb 15, 2010 |
| NITRO-DUR | Key Pharms | nitroglycerin | 5,186,938 | Feb 16, 2010 |
| SANDIMMUNE | Novartis | cyclosporine | 7,511,014 | Feb 16, 2010 |
| ALDARA | Graceway | imiquimod | 4,689,338*PED | Feb 25, 2010 |
This information is also available in an email newsletter: Subscribe to the DrugPatentWatch Patent Expiration Bulletin.Courtesy of DrugPatentWatch.com
No comments yet... Be the first to leave a reply!